These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 35059619)

  • 1. Transforming growth factor β latency: A mechanism of cytokine storage and signalling regulation in liver homeostasis and disease.
    Li Y; Fan W; Link F; Wang S; Dooley S
    JHEP Rep; 2022 Feb; 4(2):100397. PubMed ID: 35059619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subcellular localization of (latent) transforming growth factor beta and the latent TGF-beta binding protein in rat hepatocytes and hepatic stellate cells.
    Roth-Eichhorn S; Kühl K; Gressner AM
    Hepatology; 1998 Dec; 28(6):1588-96. PubMed ID: 9828223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral delivery of dominant-negative transforming growth factor beta type II receptor up-regulates transcriptional repressor SKI-like oncogene, decreases matrix metalloproteinase 2 in hepatic stellate cell and prevents liver fibrosis in rats.
    Marquez-Aguirre A; Sandoval-Rodriguez A; Gonzalez-Cuevas J; Bueno-Topete M; Navarro-Partida J; Arellano-Olivera I; Lucano-Landeros S; Armendariz-Borunda J
    J Gene Med; 2009 Mar; 11(3):207-19. PubMed ID: 19189315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent transforming growth factor-beta binding proteins (LTBPs)--structural extracellular matrix proteins for targeting TGF-beta action.
    Saharinen J; Hyytiäinen M; Taipale J; Keski-Oja J
    Cytokine Growth Factor Rev; 1999 Jun; 10(2):99-117. PubMed ID: 10743502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between growth factors and integrins: latent forms of transforming growth factor-beta are ligands for the integrin alphavbeta1.
    Munger JS; Harpel JG; Giancotti FG; Rifkin DB
    Mol Biol Cell; 1998 Sep; 9(9):2627-38. PubMed ID: 9725916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone morphogenetic protein-7 represses hepatic stellate cell activation and liver fibrosis
    Zou GL; Zuo S; Lu S; Hu RH; Lu YY; Yang J; Deng KS; Wu YT; Mu M; Zhu JJ; Zeng JZ; Zhang BF; Wu X; Zhao XK; Li HY
    World J Gastroenterol; 2019 Aug; 25(30):4222-4234. PubMed ID: 31435175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the expression pattern of the latent transforming growth factor beta binding protein isoforms in normal and diseased human liver reveals a new splice variant missing the proteinase-sensitive hinge region.
    Michel K; Roth S; Trautwein C; Gong W; Flemming P; Gressner AM
    Hepatology; 1998 Jun; 27(6):1592-9. PubMed ID: 9620332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulforaphane attenuates hepatic fibrosis via NF-E2-related factor 2-mediated inhibition of transforming growth factor-β/Smad signaling.
    Oh CJ; Kim JY; Min AK; Park KG; Harris RA; Kim HJ; Lee IK
    Free Radic Biol Med; 2012 Feb; 52(3):671-682. PubMed ID: 22155056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neovessel formation promotes liver fibrosis via providing latent transforming growth factor-β.
    Sakata K; Eda S; Lee ES; Hara M; Imoto M; Kojima S
    Biochem Biophys Res Commun; 2014 Jan; 443(3):950-6. PubMed ID: 24361885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of isoforms and splice variants of the latent transforming growth factor beta binding protein (LTBP) in cultured human liver myofibroblasts.
    Mangasser-Stephan K; Gartung C; Lahme B; Gressner AM
    Liver; 2001 Apr; 21(2):105-13. PubMed ID: 11318979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta.
    Bourd-Boittin K; Bonnier D; Leyme A; Mari B; Tuffery P; Samson M; Ezan F; Baffet G; Theret N
    Hepatology; 2011 Dec; 54(6):2173-84. PubMed ID: 21826695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of latent TGF-beta by thrombospondin-1: mechanisms and physiology.
    Murphy-Ullrich JE; Poczatek M
    Cytokine Growth Factor Rev; 2000; 11(1-2):59-69. PubMed ID: 10708953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy.
    Tamaki K; Okuda S; Miyazono K; Nakayama M; Fujishima M
    Lab Invest; 1995 Jul; 73(1):81-9. PubMed ID: 7603044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and matrix deposition of latent transforming growth factor beta binding proteins in normal and fibrotic rat liver and transdifferentiating hepatic stellate cells in culture.
    Breitkopf K; Lahme B; Tag CG; Gressner AM
    Hepatology; 2001 Feb; 33(2):387-96. PubMed ID: 11172340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L(59) TGF-β LAP degradation products serve as a promising blood biomarker for liver fibrogenesis in mice.
    Hara M; Inoue I; Yamazaki Y; Kirita A; Matsuura T; Friedman SL; Rifkin DB; Kojima S
    Fibrogenesis Tissue Repair; 2015; 8():17. PubMed ID: 26379781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (Latent) transforming growth factor beta in liver parenchymal cells, its injury-dependent release, and paracrine effects on rat hepatic stellate cells.
    Roth S; Michel K; Gressner AM
    Hepatology; 1998 Apr; 27(4):1003-12. PubMed ID: 9537440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and release of the latent transforming growth factor beta binding protein by hepatocytes from rat liver.
    Roth S; Schurek J; Gressner AM
    Hepatology; 1997 Jun; 25(6):1398-405. PubMed ID: 9185759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isorhamnetin attenuates liver fibrosis by inhibiting TGF-β/Smad signaling and relieving oxidative stress.
    Yang JH; Kim SC; Kim KM; Jang CH; Cho SS; Kim SJ; Ku SK; Cho IJ; Ki SH
    Eur J Pharmacol; 2016 Jul; 783():92-102. PubMed ID: 27151496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.